Skip to Main content Skip to Navigation
New interface
Journal articles

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03623726
Contributor : François Bertucci Connect in order to contact the contributor
Submitted on : Tuesday, March 29, 2022 - 6:47:05 PM
Last modification on : Tuesday, November 22, 2022 - 2:26:16 PM

Identifiers

Citation

Olivier Mir, Thomas Brodowicz, Antoine Italiano, Jennifer Wallet, Jean-Yves Blay, et al.. Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncology, 2016, 17 (12), pp.1732-1742. ⟨10.1016/s1470-2045(16)30507-1⟩. ⟨hal-03623726⟩

Share

Metrics

Record views

22